It is suggested that tumors frequently show oligoclonal origin, moreover, cell evolution produced more genetically related but different cell clones. Those about mentioned clones raised new challenge to the targeted therapy and genetic diagnosis. Currently the population based methods may address this issue partially. If any current technologies could ideally address poli/oligo-clonal, or sub-clones from the clonal evolution?

More Shaobo Zhang's questions See All
Similar questions and discussions